We are live on ! Find out more
LUCD icon

Lucid Diagnostics

103 hedge funds and large institutions have $41M invested in Lucid Diagnostics in 2026 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

68% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 19

17% more capital invested

Capital invested by funds: $35.1M → $41M (+$5.84M)

16% more funds holding

Funds holding: 89103 (+14)

3.25% less ownership

Funds ownership: 23.37%20.13% (-3.2%)

Holders
103
Holders Change
+14
Holders Change %
+15.73%
% of All Funds
1.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
32
Reduced
19
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$5.33M +$414K +325,605 +8%
VCM
2
Vanguard Capital Management
Pennsylvania
$4.78M +$5.29M +4,154,770 New
MCM
3
Masters Capital Management
Georgia
$4.6M
Aberdeen Group
4
Aberdeen Group
United Kingdom
$4.19M +$237K +186,383 +5%
TSC
5
Two Seas Capital
New York
$3.45M
Geode Capital Management
6
Geode Capital Management
Massachusetts
$2.58M +$278K +218,523 +11%
Russell Investments Group
7
Russell Investments Group
United Kingdom
$1.82M +$2M +1,573,481 +15,537%
State Street
8
State Street
Massachusetts
$1.79M +$257K +201,626 +15%
Wells Fargo
9
Wells Fargo
California
$1.47M +$452K +354,911 +39%
PCM
10
Perkins Capital Management
Minnesota
$1.29M
SS
11
Sunbelt Securities
Texas
$1.04M +$657K +516,014 +134%
Northern Trust
12
Northern Trust
Illinois
$771K +$42.7K +33,571 +5%
VFT
13
Vanguard Fiduciary Trust
Pennsylvania
$717K +$794K +623,557 New
VPM
14
Vanguard Portfolio Management
Pennsylvania
$608K +$673K +528,769 New
Raymond James Financial
15
Raymond James Financial
Florida
$604K +$668K +524,936 New
Renaissance Technologies
16
Renaissance Technologies
New York
$575K -$416K -326,866 -40%
UBS Group
17
UBS Group
Switzerland
$512K +$173K +135,985 +44%
Lido Advisors
18
Lido Advisors
California
$441K
First Manhattan
19
First Manhattan
New York
$372K
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
$328K +$345K +270,990 +1,902%
Goldman Sachs
21
Goldman Sachs
New York
$279K -$59.3K -46,617 -16%
AQR Capital Management
22
AQR Capital Management
Connecticut
$270K +$195K +153,208 +188%
XF
23
XML Financial
Maryland
$257K +$56.5K +44,400 +25%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$237K +$4.46K +3,506 +2%
Charles Schwab
25
Charles Schwab
California
$227K -$35K -27,497 -12%

LUCD Hedge Fund Activity: Q1 2026 in Review

103 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q1 2026, worth a combined $41M — up 17% from $35.1M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new LUCD positions and 11 closed out — a net gain of 15 holders — while 32 added to existing stakes and 19 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $2M. The largest seller was Renaissance Technologies, cutting an estimated $416K.

  • 103 institutional investors held Lucid Diagnostics (LUCD) as of Q1 2026, up from 89 in Q4 2025.
  • Funds reported $41M of Lucid Diagnostics stock for Q1 2026, up 17% quarter-over-quarter.
  • 26 funds opened new Lucid Diagnostics positions in Q1 2026 and 11 closed out, a net change of +15 holders.
  • The largest Lucid Diagnostics buyer in Q1 2026 was Russell Investments Group, an estimated $2M added.
  • The largest Lucid Diagnostics seller in Q1 2026 was Renaissance Technologies, an estimated $416K sold.

Based on aggregated 13F filings for Q1 2026.